Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A Jiménez Morales
Observed names:
A Jimenez Morales,
A Morales,
A. Jiménez Morales
Institution:
Hospital Universitario Virgen de las Nieves
Observed institutions:
Hospital Universitario Nuestra Señora de Candelaria,
Hospital Universitario Virgen de las Nieves,
Complejo Hospitalario Universitario de Granada
ORCID:
0009-0000-4051-1866
Observed ORCID:
0009-0000-4051-1866
OpenAlex ID:
A5029024804
Manejo de los efectos adversos de apremilast desde un abordaje multidisciplinar
2020
·
E. Daudén Tello
, J. Alonso Suárez
, et al.
·
Actas Dermo-Sifiliográficas
·
10
PDF
Multidisciplinary Management of the Adverse Effects of Apremilast
2020
·
E. Daudén Tello
, J. Alonso Suárez
, et al.
·
Actas Dermo-Sifiliográficas
·
5
PDF
Review and case report: Hepatoid adenocarcinoma of the lung treated with nivolumab metastatizing to the skin
2019
·
Bárbara Cancela Díez
, Félix Rueda
, et al.
·
European journal of clinical pharmacy
·
3
4CPS-183 Multicentre study: evaluation of the effectiveness and safety of upadacitinib in inflammatory bowel disease
2025
·
A Gómez Balazote
, Á García López
, et al.
·
European Journal of Hospital Pharmacy
·
2
PDF
5PSQ-065 Prediction of toxicity of methotrexate by means of genetic tests in patients diagnosed with moderate–severe psoriasis
2020
·
C Membrive
, C Perez Ramírez
, et al.
·
European Journal of Hospital Pharmacy
·
2
PDF
PS-128 Thrombotic microangiopathy associated with the use of ciclosporin in prophylaxis of graft-versus-host disease in patients undergoing allogeneic haematopoietic stem cell transplantation
2015
·
C Alarcón-Payer
, M Jurado Chacón
, et al.
·
European Journal of Hospital Pharmacy
·
2
[Boceprevir and telaprevir safety in routine clinical practice].
2014
·
R López-Sepúlveda
, C Fernández-López
, et al.
·
PubMed
·
2
Cost-consequence Analysis of Secukinumab vs Adalimumab in Moderate-to-severe Hidradenitis Suppurativa
2025
·
A. Martorell
, A. Molina-Leyva
, et al.
·
Actas Dermo-Sifiliográficas
·
1
5PSQ-087 Analysis of effectiveness and safety of tralokinumab in moderate-severe atopic dermatitis
2024
·
AY Salmeron Cobos
, MÁ Urbano Fernández
, et al.
·
European Journal of Hospital Pharmacy
·
1
PDF
4CPS-208 Analysis of the implementation of a multidisciplinary pharmaceutical care project for geriatric haemato-oncology patients
2024
·
C Alarcon-Payer
, MDM Sánchez Suárez
, et al.
·
European Journal of Hospital Pharmacy
·
1
PDF
CP-024 Pharmaceutical interventions with zolpidem in elderly patients
2016
·
M Navarro
, I Plasencia
, et al.
·
European Journal of Hospital Pharmacy
·
1
6ER-011 Influence of JAK/STAT single nucleotide polymorphisms and cardiovascular events during treatment of rheumatoid arthritis patients in a tertiary level hospital
2026
·
A Martín Roldán
, N Márquez Pete
, et al.
·
European Journal of Hospital Pharmacy
5PSQ-056 Pharmaceutical interventions and toxicity monitoring in patients with melanoma treated with encorafenib and binimetinib
2026
·
MDM Sánchez Suárez
, A Martín Roldan
, et al.
·
European Journal of Hospital Pharmacy
5PSQ-053 Implementation of a personalised telepharmacy model in oncological patients
2026
·
MDM Sánchez Suárez
, A Martín Roldán
, et al.
·
European Journal of Hospital Pharmacy
4CPS-087 Optimising haemophilia management: enhancing treatment adherence and quality of life with innovative therapies
2026
·
A Martín Roldán
, MDM Sánchez Suárez
, et al.
·
European Journal of Hospital Pharmacy
6ER-012 Abstract withdrawn
2026
·
A Martín Roldán
, MDM Sánchez Suarez
, et al.
·
European Journal of Hospital Pharmacy
4CPS-082 Detection of medication errors and unmet needs of oncology patients during the oncology pharmacy practice visit
2025
·
C Alarcon-Payer
, A Martín Roldán
, et al.
·
European Journal of Hospital Pharmacy
PDF
5PSQ-047 Dynamics of HIV pre-exposure prophylaxis use and evaluation of its impact in the incidence of sexually transmitted diseases
2025
·
A Martín Roldán
, MDM Sánchez Suárez
, et al.
·
European Journal of Hospital Pharmacy
PDF
4CPS-050 Multicentre evaluation of migraine preventive treatment with calcitonin gene-related peptide receptor antibodies efficacy after a therapeutic holiday
2025
·
A Martín Roldán
, MDM Sánchez Suárez
, et al.
·
European Journal of Hospital Pharmacy
PDF
4CPS-081 Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia in first or second-line
2025
·
C Alarcon-Payer
, MDM Sánchez Suárez
, et al.
·
European Journal of Hospital Pharmacy
PDF
4CPS-080 Economic impact associated to biological therapy optimisation in patients with psoriasis
2025
·
Á García López
, MR Cantudo-Cuenca
, et al.
·
European Journal of Hospital Pharmacy
PDF
4CPS-237 Special pharmaceutical care and teleconsultation for the geriatric oncohaematological patient
2025
·
C Alarcón-Payer
, A Martín Roldán
, et al.
·
European Journal of Hospital Pharmacy
PDF
5PSQ-104 Atezolizumab together with chemotherapy in patients with small-cell lung cancer in a tertiary hospital
2025
·
AY Salmerón Cobos
, MJ Gándara Ladrón de Guevara
, et al.
·
European Journal of Hospital Pharmacy
PDF
4CPS-083 Discontinuation of lenalidomide treatment in patients with myelodysplastic syndrome associated with 5q deletion
2025
·
C Alarcon-Payer
, A Martín Roldán
, et al.
·
European Journal of Hospital Pharmacy
PDF
5PSQ-003 Impact of pharmacist interventions in elderly patients with polypharmacy
2025
·
C Montero-Vilchez
, MDM García-Valdés
, et al.
·
European Journal of Hospital Pharmacy
PDF
Show more works
View as search
Works count:
63
Citation count:
30
H-index:
3
I10-index:
1
Year
Topic
Type